The purpose of this procurement is to conclude a framework contract for the purchase of medicinal products for use in the provision of healthcare services on the basis of the names and descriptions given in Annex 1 to the HD.
B03AC01/ B03AC80 Pikatoimeline rauapreparaatSüstelahus I/V
J06BB16 Palivizumabinj. Subst
L04AC02 Basiliximabinj. Subst
L04AA36 Ocrelizumabinf.conc.
L04AC14 Sarilumabpensüstel
L01FX04 Ipilimumabinf. conc.
L01DB11 Pixantroninf.plv.
L01XC24 DaratumumabSubcutaneous solution for injection
L01XC19 Blinatumomabinf.lah. heel. powder and solution
L01XE02 Gefitinibtabl.
L01XY02 Pertuzumab +trastuzumabSubcutaneous solution for injection
B03AC02 /B03AC06 Lühitoimeline rauapreparaatSüstelahus I/V
L01XY02 Pertuzumab +trastuzumabSubcutaneous solution for injection
L04AA26 Belimumabpensüstel
L04AC13 Isekizumabpensüstel
M05BX05 Burosumabsüstevedelik
M05BX05 Burosumabsüstevedelik
B06AC05 Lanadelumabinf.
C10AX13 Evolocumabpensüstel
C10AX14 Alirocumabpensüstel
D11AH05 Dupilimumabpensüstel
D11AH05 Dupilimumabpensüstel
J05AX10 Maribaviirtray
J06BB16 Palivizumabinj. Subst